Cancer cell differentiation heterogeneity and aggressive behavior in solid tumors

References

• Hay ED. The mesenchymal cell, its role in the embryo, and the remarkable signaling mechanisms that create it. Dev Dyn. 2005;233:706–20.
   PubMed Web of Science ®Google Scholar
• Boström A-K, Möller C, Nilsson E, Elfving P, Axelson H, Johansson ME. Sarcomatoid renal cell carcinoma may denote a biological example of epithelial to mesenchymal transition. Hum Pathol. 2011.
   PubMed Web of Science ®Google Scholar
• Cushing H, Wolbach SB. The transformation of a malignant paravertebral sympathicoblastoma into a benign ganglioneuroma. Am J Pathol. 1927;3(3):203–216.
   PubMedGoogle Scholar
• Fredlund E, Ringner M, Maris JM, Påhlman S. High Myc pathway activity and low stage of neuronal differentiation associate with poor outcome in neuroblastoma. Proc Natl Acad Sci USA. 2008;105:14094–9.
   PubMed Web of Science ®Google Scholar
• Påhlman S, Odelstad L, Larsson E, Grotte G, Nilsson K. Phenotypic changes of human neuroblastoma cells in culture induced by 12-O-tetradecanoyl-phorbol-13-acetate. Int J Cancer. 1981;28:583–9.
   PubMed Web of Science ®Google Scholar
• Sidell N. Retinoic acid-induced growth inhibition and morphologic differentiation of human neuroblastoma cells in vitro. J Natl Cancer Inst. 1982;68:589–96.
   PubMed Web of Science ®Google Scholar
• Hedborg F, Ohlsson R, Sandstedt B, Grimelius L, Hoehner JC, Påhlman S. IGF2 expression is a marker for paraganglionic/SIF cell differentiation in neuroblastoma. Am J Pathol. 1995;146:833–47.
   PubMed Web of Science ®Google Scholar
• Gestblom C, Hoehner JC, Hedborg F, Sandstedt B, Påhlman S. In vivo spontaneous neuronal to neuroendocrine lineage conversion in a subset of neuroblastomas. Am J Pathol. 1997;150:107–17.
   PubMed Web of Science ®Google Scholar
• Höckel M, Vaupel P. Tumor hypoxia: Definitions and current clinical, biologic, and molecular aspects. J Natl Cancer Inst. 2001;93:266–76.
   PubMed Web of Science ®Google Scholar
• Semenza GL, Roth PH, Fang HM, Wang GL. Transcriptional regulation of genes encoding glycolytic enzymes by hypoxia-inducible factor 1. J Biol Chem. 1994;269:23757–63.
   PubMed Web of Science ®Google Scholar
• Semenza GL. Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics. Oncogene. 2010;29:625–34.
   PubMed Web of Science ®Google Scholar
• Löfstedt T, Fredlund E, Holmquist-Mengelbier L, Pietras A, Ovenberger M, Poellinger L, Hypoxia inducible factor-2alpha in cancer. Cell Cycle. 2007;6:919–26.
   PubMed Web of Science ®Google Scholar
• Jögi A, Persson P, Grynfeld A, Påhlman S, Axelson H. Modulation of basic helix-loop-helix transcription complex formation by Id proteins during neuronal differentiation. J Biol Chem. 2002;277:9118–26.
   PubMed Web of Science ®Google Scholar
• Jögi A, Vallon-Christersson J, Holmquist L, Axelson H, Borg A, Påhlman S. Human neuroblastoma cells exposed to hypoxia: induction of genes associated with growth, survival, and aggressive behavior. Exp Cell Res. 2004;295:469–87.
   PubMed Web of Science ®Google Scholar
• Pietras A, Johnsson AS, Påhlman S. The HIF-2alpha-driven pseudo-hypoxic phenotype in tumor aggressiveness, differentiation, and vascularization. Curr Top Microbiol Immunol. 2010;345:1–20.
   PubMed Web of Science ®Google Scholar
• Kaelin WG Jr, Ratcliffe PJ. Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway. Mol Cell. 2008;30:393–402.
   PubMed Web of Science ®Google Scholar
• Holmquist-Mengelbier L, Fredlund E, Löfstedt T, Noguera R, Navarro S, Nilsson H, Recruitment of HIF-1 alpha and HIF-2 alpha to common target genes is differentially regulated in neuroblastoma: HIF-2 alpha promotes an aggressive phenotype. Cancer Cell. 2006;10:413–23.
   PubMed Web of Science ®Google Scholar
• Pietras A, Gisselsson D, Øra I, Noguera R, Beckman S, Navarro S, High levels of HIF-2alpha highlight an immature neural crest-like neuroblastoma cell cohort located in a perivascular niche. J Pathol. 2008;214:482–8.
   PubMed Web of Science ®Google Scholar
• Noguera R, Fredlund E, Piqueras M, Pietras A, Beckman S, Navarro S, HIF-1alpha and HIF-2alpha are differentially regulated in vivo in neuroblastoma: high HIF-1alpha correlates negatively to advanced clinical stage and tumor vascularization. Clin Cancer Res. 2009;15:7130–6.
   PubMed Web of Science ®Google Scholar
• Li Z, Bao S, Wu Q, Wang H, Eyler C, Sathornsumetee S, Hypoxia-inducible factors regulate tumorigenic capacity of glioma stem cells. Cancer Cell. 2009;15:501–13.
   PubMed Web of Science ®Google Scholar
• Pietras A, Hansford LM, Johnsson AS, Bridges E, Sjölund J, Gisselsson D, HIF-2alpha maintains an undifferentiated state in neural crest-like human neuroblastoma tumor-initiating cells. Proc Natl Acad Sci USA. 2009;106:16805–10.
   PubMed Web of Science ®Google Scholar
• Brisken C, Duss S. Stem cells and the stem cell niche in the breast: an integrated hormonal and developmental perspective. Stem Cell Rev. 2007;3:147–56.
   PubMed Web of Science ®Google Scholar
• Helczynska K, Kronblad A, Jögi A, Nilsson E, Beckman S, Landberg G, Hypoxia promotes a dedifferentiated phenotype in ductal breast carcinoma in situ. Cancer Res. 2003;63:1441–4.
   PubMed Web of Science ®Google Scholar
• Vaapil et al., unpublished paper.
   Google Scholar
• Jögi A, Helczynska K, Vaapil M, Johansson E, Beckman S, Larsson C, Hypoxia impairs morphological and functional differentiation of immortalized human breast epithelial cells in 3D basement membrane matrix-culture. Abstract #235. AACR Annual Conference. AACR 100th Annual Meeting, Denver, Colorado, April 18-22. 2009.
   Google Scholar
• Helczynska K, Larsson AM, Holmquist Mengelbier L, Bridges E, Fredlund E, Borgquist S, Hypoxia-inducible factor-2alpha correlates to distant recurrence and poor outcome in invasive breast cancer. Cancer Res. 2008;68:9212–20.
   Google Scholar
• Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA. 2003;100:3983–8.
   PubMed Web of Science ®Google Scholar
• Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan A, Zhou AY, The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell. 2008;133:704–15.
   PubMed Web of Science ®Google Scholar
• Haase VH. Oxygen regulates epithelial-to-mesenchymal transition: insights into molecular mechanisms and relevance to disease. Kidney Int. 2009;76:492–9.
   Google Scholar
• Hoehner JC, Gestblom C, Hedborg F, Sandstedt B, Olsen L, Påhlman S. A developmental model of neuroblastoma: differentiating stroma-poor tumors' progress along an extra-adrenal chromaffin lineage. Lab Invest. 1996;75:659–75.
   PubMed Web of Science ®Google Scholar
• Odelstad L, Pahlman S, Nilsson K, Larsson E, Lackgren G, Johansson KE, Neuron-specific enolase in relation to differentiation in human neuroblastoma. Brain Res. 1981;224:69–82.
   PubMed Web of Science ®Google Scholar
• Piccirillo SG, Reynolds BA, Zanetti N, Lamorte G, Binda E, Broggi G, Bone morphogenetic proteins inhibit the tumorigenic potential of human brain tumour-initiating cells. Nature. 2006;444:761–5.
   PubMed Web of Science ®Google Scholar
• Lee J, Son MJ, Woolard K, Donin NM, Li A, Cheng CH, Epigenetic-mediated dysfunction of the bone morphogenetic protein pathway inhibits differentiation of glioblastoma-initiating cells. Cancer Cell. 2008;13:69–80.
   PubMed Web of Science ®Google Scholar